Literature DB >> 23697959

Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis.

Sung Chul Park1, Yungtai Kung, Daniel Su, Joseph L Simonson, Rafael L Furlanetto, Jeffrey M Liebmann, Robert Ritch.   

Abstract

OBJECTIVE: To compare the performance of 10-2 versus 24-2 visual fields (VFs) in detecting progression of initial parafoveal scotoma (IPFS) in glaucomatous eyes.
DESIGN: Retrospective, observational study. PARTICIPANTS: Glaucoma patients with the following criteria: (1) an IPFS (≥ 3 adjacent points with P<0.05 within the central 10° degrees of fixation, 1 point or more with P<0.01 lying at the innermost paracentral points, and no scotoma outside the central 10°) in either hemifield based on 2 reliable Humphrey 24-2 Swedish interactive threshold algorithm standard VFs, and (2) 5 or more 10-2 and 24-2 VFs.
METHODS: Based on threshold map sensitivities, VF progression, defined as having 1 or more significantly progressing point(s) with a slope of sensitivity of less than -1.0 dB/year at P<0.01, was evaluated using pointwise linear regression. MAIN OUTCOME MEASURES: The number of progressing eyes in 10-2 and 24-2 VF analyses.
RESULTS: Fifty eyes (50 patients) were included (mean age ± standard deviation, 62 ± 9 years). Mean follow-up period (5.7 vs. 5.6 years) and number of VFs (7.6 vs. 7.8) were similar between 10-2 and 24-2 analyses (all P>0.3). Significantly more progressing eyes were detected in 10-2 than in 24-2 analyses (24 vs. 11 eyes; P = 0.007). This difference became greater within the central 10° (24 vs. 4 eyes; P<0.001). Four of the 11 progressing eyes in 24-2 analysis were missed in 10-2 analysis, whereas 17 of the 24 progressing eyes in 10-2 analysis were missed in 24-2 analysis. The 4 progressing eyes missed in 10-2 analysis had progressing point(s) only outside the central 10° in 24-2 analysis. The other 3 eyes with progressing point(s) only outside the central 10° in 24-2 analysis were detected as progressing in 10-2 analysis. Similar results were obtained when more stringent criteria (at least 2 significantly progressing points within the same hemifield) were used for VF progression.
CONCLUSIONS: The 10-2 VF detects more progressing eyes than the 24-2 VF in glaucoma patients with IPFS, suggesting that closer surveillance of the central VF using testing algorithms with closely spaced grids is warranted in eyes with parafoveal scotomas. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23697959     DOI: 10.1016/j.ophtha.2013.01.045

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

1.  Comparative glaucomatous diagnosis using macular optical coherence tomography and perimetry with centrally condensed stimuli: English version.

Authors:  A Sturm; W Noske
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

Review 2.  [Correlation of morphological and functional glaucoma diagnostics with macular OCT and perimetry with centrally condensed stimuli: German version].

Authors:  A Sturm; W Noske
Journal:  Ophthalmologe       Date:  2015-08       Impact factor: 1.059

Review 3.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

4.  Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmol Glaucoma       Date:  2019-01-14

5.  Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.

Authors:  Dana M Blumberg; Carlos Gustavo De Moraes; Alisa J Prager; Qi Yu; Lama Al-Aswad; George A Cioffi; Jeffrey M Liebmann; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

6.  One Year of Glaucoma Research in Review: 2012 to 2013.

Authors:  Charles Kim; Anna M Demetriades; Nathan M Radcliffe
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2014 Jan-Feb

Review 7.  Macular imaging with optical coherence tomography in glaucoma.

Authors:  Vahid Mohammadzadeh; Nima Fatehi; Adeleh Yarmohammadi; Ji Woong Lee; Farideh Sharifipour; Ramin Daneshvar; Joseph Caprioli; Kouros Nouri-Mahdavi
Journal:  Surv Ophthalmol       Date:  2020-03-19       Impact factor: 6.048

8.  Visual Field Inference From Optical Coherence Tomography Using Deep Learning Algorithms: A Comparison Between Devices.

Authors:  Jonghoon Shin; Sungjoon Kim; Jinmi Kim; Keunheung Park
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

9.  Quantification of the Peripapillary Microvasculature in Eyes with Glaucomatous Paracentral Visual Field Loss.

Authors:  Rafaella Nascimento E Silva; Carolina A Chiou; Mengyu Wang; Julia Devlin; Dian Li; Sydney Lovelace; Haobing Wang; Scott H Greenstein; Stacey C Brauner; Lucy Q Shen
Journal:  Ophthalmol Glaucoma       Date:  2020-10-16

10.  Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage.

Authors:  Ryan Caezar C David; Sasan Moghimi; Jiun L Do; Huiyuan Hou; James Proudfoot; Linda M Zangwill; Alireza Kamalipour; Takashi Nishida; Carlos Gustavo De Moraes; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2021-06-06       Impact factor: 5.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.